Trial Profile
A PHASE 1, OPEN-LABEL, CROSS-OVER, FIXED SEQUENCE STUDY TO EVALUATE THE EFFECT OF MULTIPLE DOSES OF DS-1971A ON THE SINGLE DOSE PHARMACOKINETICS OF PROBE SUBSTRATES FOR CYP2B6, CYP2C8, CYP2C9, CYP2C19 AND CYP3A4 ENZYMES IN HEALTHY MALE AND FEMALE SUBJECTS
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Feb 2024
Price :
$35
*
At a glance
- Drugs DS-1971 (Primary) ; Bupropion; Midazolam; Omeprazole; Pioglitazone; Tolbutamide
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Daiichi Sankyo Inc
- 04 Nov 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jun 2015 New trial record